EUVIMEDEUVIMED entdecken
Crossref

Changes in high-sensitivity C-reactive protein testing and distribution across the COVID-19 pandemic: a 17-year laboratory-based study

Jeong Su Han iD, Jae-Sik Jeon iD, Jae Kyung Kim iD

Laboratory Medicine · 05.10.2026 · 57 (6)

DOI: 10.1093/labmed/lmag084 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Laboratory Medicine, online erschienen am 28.10.2026. Verfasst von Jeong Su Han und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Laboratory Science, College of Health Sciences, Dankook University, Cheonan-si, Republic of Korea. Hauptthemen laut MEDLINE: C-Reactive Protein, COVID-19. Die Arbeit nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

COVID-19 altered health care utilization and laboratory testing. We assessed changes in routine high-sensitivity C-reactive protein (hs-CRP) testing and distributions across the pandemic.

Methods

We retrospectively analyzed hs-CRP results from a tertiary-care medical center from 2007 through 2023. We included 314 106 episodes from 116 505 patients. Annual testing volume, median values, upper-tail percentiles, and threshold categories were assessed, and distributions were compared across the prepandemic (2007-2019), pandemic (2020-2022), and postpandemic (2023) periods.

Results

The hs-CRP distribution was right skewed (median, 0.050 mg/dL; 95th and 99th percentiles, 0.440 mg/dL and 1.060 mg/dL, respectively). Annual median values remained stable, but upper percentiles and the proportion of hs-CRP results 0.3 mg/dL or higher declined (annual odds ratio, 0.985 [95% CI, 0.983-0.988]). During 2020-2022, hs-CRP values below 0.1 mg/dL were more frequent and values at or above 0.3 mg/dL less frequent than before the pandemic.

Discussion

Pandemic-period differences occurred against a preexisting decline in upper-tail hs-CRP values. These findings should be interpreted in their long-term context, considering testing volume and result distributions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

C-Reactive ProteinCOVID-19HumansRetrospective StudiesPandemicsSARS-CoV-2

Stichwörter der Autor:innen

COVID-19biomarkerclinical chemistryhigh-sensitivity C-reactive proteininflammationlaboratory surveillance

Substanzen

C-Reactive Protein

Autor:innen und Institutionen

  • Department of Biomedical Laboratory Science, College of Health Sciences, Dankook University, Cheonan-si, Republic of Korea.

ORCID-Profile: Jeong Su Han, Jae-Sik Jeon, Jae Kyung Kim

Zitieren

APA

Han, J. S., Jeon, J. S., & Kim, J. K. (2026). Changes in high-sensitivity C-reactive protein testing and distribution across the COVID-19 pandemic: a 17-year laboratory-based study. Laboratory Medicine, 57(6). https://doi.org/10.1093/labmed/lmag084

Vancouver

Han JS, Jeon JS, Kim JK. Changes in high-sensitivity C-reactive protein testing and distribution across the COVID-19 pandemic: a 17-year laboratory-based study. Laboratory Medicine. 2026;57(6). doi:10.1093/labmed/lmag084

BibTeX
@article{Han2026,
  author = {Han, Jeong Su and Jeon, Jae-Sik and Kim, Jae Kyung},
  title = {Changes in high-sensitivity C-reactive protein testing and distribution across the COVID-19 pandemic: a 17-year laboratory-based study},
  journal = {Laboratory Medicine},
  year = {2026},
  volume = {57},
  number = {6},
  doi = {10.1093/labmed/lmag084}
}
Kostenlos starten →